Diagnostic capabilities, clinical features, and longitudinal <scp><i>UBA1</i></scp> clonal dynamics of a nationwide <scp>VEXAS</scp> cohort
Carmelo Gurnari(University of Rome Tor Vergata), Maria Teresa Voso(University of Rome Tor Vergata), Federica Pilo(University of Cagliari), Giulia Falconi(University of Rome Tor Vergata), Raffaella Greco(Vita-Salute San Raffaele University), Franco Franceschini(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Attilio Olivieri(Ospedali Riuniti di Ancona), Antonio Vitale(University of Siena), Paola Triggianese(University of Rome Tor Vergata), Elisa Diral(Vita-Salute San Raffaele University), Giorgia Battipaglia(Federico II University Hospital), Lorenzo Dagna(Vita-Salute San Raffaele University), Diego Bertoli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Elena Crisà(Candiolo Cancer Institute), Massimo Bernardi(Vita-Salute San Raffaele University), Paolo Sfriso(University of Padua), Francesca Crisafulli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Alessandro Tomelleri(Vita-Salute San Raffaele University), Sara Bindoli(University of Padua), Corrado Campochiaro(Vita-Salute San Raffaele University), Alessandro Bruno(Vita-Salute San Raffaele University), Chiara Cattaneo(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Cristina Papayannidis(University of Bologna), Pellegrino Musto(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Federico Caroni(University of Siena), Shahram Kordasti(Guy's Hospital), Flavia Mallegni(University of Rome Tor Vergata), Maria Rosaria Pascale(University of Rome Tor Vergata), Marco Frigeni(Ospedale Papa Giovanni XXIII), Elisa Galossi(University of Rome Tor Vergata), Luca Cantarini(University of Siena), Fabrizio Pane(Ceinge Biotecnologie Avanzate (Italy)), Davide Firinu(University of Cagliari), Antonio Curti(University of Bologna), Francesco Albano(Centro di Riferimento Oncologico della Basilicata), Matteo Dragani(Ospedale Policlinico San Martino), Luisa Brussino(A. O. Ordine Mauriziano di Torino), Erika Morsia(Marche Polytechnic University), Elisabetta Lugli(Azienda Sanitaria Unità Locale di Reggio Emilia), Micol Frassi(University of Brescia), Antonella Poloni(Marche Polytechnic University), Massimo Breccia(San Antonio College), Monica Bocchia(University of Siena), Annalisa Condorelli(Ospedale Papa Giovanni XXIII), Daniela Caravelli(Candiolo Cancer Institute)
Cited by 43
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
|Frontiers in Pharmacology|2019|616
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure
|New England Journal of Medicine|2019|464